Pfizer faced a setback with its combo Covid-flu shot, which could allow Moderna and others to gain ground. Meanwhile, Epic’s UGM meeting is underway.
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox.and Novavax, among other companies, hope that more convenient combo shots offering protection against two viruses rather than one will increase uptake among Americans.
"We remain optimistic about our combination COVID-19 and influenza program, for which we are evaluating the next steps," said Annaliesa Anderson, Pfizer's head of vaccine research and development, in the release. Moderna plans to file for regulatory approval for that shot and hopes it can enter the market in 2025.
Epic is a health-care software giant whose technology is used in thousands of hospitals and clinics across the country. Its 1,670-acre headquarters is nestled about 30 minutes away from Madison, and thousands of health-care leaders are gathered here to talk tech this week. But if that isn't enough to pique your interest, Epic executives will also deliver the address in costume. This year's UGM is"storytime" themed, according to theAs far as announcements go, I expect we'll hear a lot about Epic's work to integrate artificial intelligence into its software.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Healthy bees, healthy planet: The impact of balanced diets on honeybee coloniesA new study from the Hebrew University of Jerusalem has revealed that a balanced diet is essential for the optimal health and task performance of honeybees, a key species for pollination and ecosystem stability. The study, led by Prof. Sharoni Shafir from the Robert H.
Read more »
Healthy Returns: The first round of Medicare drug price negotiations is nearing an endThe first round of Biden’s Medicare drug price negotiations is nearly finished. Meanwhile, Abridge, Epic and Mayo Clinic are bringing AI tools to nurses.
Read more »
Healthy Returns: The first round of Medicare drug price negotiations is nearing an endThe first round of Biden’s Medicare drug price negotiations is nearly finished. Meanwhile, Abridge, Epic and Mayo Clinic are bringing AI tools to nurses.
Read more »
Healthy Returns: Here's what GLP-1s are being tested for beyond weight loss, diabetesThe list of potential health benefits from GLP-1 is only getting longer. Meanwhile, the heads of Commure, Augmedix share details about an acquisition.
Read more »
Healthy Returns: Here's what GLP-1s are being tested for beyond weight loss, diabetesThe list of potential health benefits from GLP-1 is only getting longer. Meanwhile, the heads of Commure, Augmedix share details about an acquisition.
Read more »
Healthy Returns: What drugmakers are saying about final negotiated prices with MedicareDrugmakers appear to be less concerned about the impact of negotiated prices on their businesses in the short term. Meanwhile, health care heads to Hollywood.
Read more »